Shares of Alliance Pharma plc (LON:APH – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 52.26 ($0.68) and traded as high as GBX 64.50 ($0.84). Alliance Pharma shares last traded at GBX 64.20 ($0.83), with a volume of 476,889 shares traded.
Analysts Set New Price Targets
Separately, Berenberg Bank lowered shares of Alliance Pharma to a “hold” rating and reduced their target price for the stock from GBX 7,000 ($90.90) to GBX 6,250 ($81.16) in a report on Wednesday, January 29th.
Read Our Latest Analysis on APH
Alliance Pharma Trading Up 0.2 %
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Featured Articles
- Five stocks we like better than Alliance Pharma
- Industrial Products Stocks Investing
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Invest in Insurance Companies: A Guide
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.